Skip to content
Search

Latest Stories

Too old? Too slow? No! Debut marathon runners may add years to life

First-time marathon runners can add years to their lives and reap the health rewards of lower blood pressure and healthier arteries, even if they take on the challenge in mid- to later life, research showed on Monday.

"It appears to never be too late," said co-lead researcher Charlotte Manisty of University College London.


The Marathon Study showed the biggest health gains were in slower, older men who also had relatively high blood pressure when training began, though the researchers said it was not clear why they benefited most.

In the study, published in the Journal of the American College of Cardiology, Manisty's team looked at 138 first-time marathon runners from the 2016 and 2017 London Marathon.

On average, the new runners were 37 years old and 49 per cent were male, and were not running for more than two hours per week before the study began. The average marathon time at the end of the study was 5.4 hours for women and 4.5 hours for men.

The scientists examined the participants before training and after they had completed the 26.2-mile (42 km) event to see if successfully taking on a marathon had affected their levels of arterial stiffening.

Hardening of the arteries is a normal part of ageing. It increases the risk of cardiovascular diseases such as stroke and heart attack and related conditions which are also linked to dementia and kidney disease.

The first-time marathon runners in the study saw, on average, a decrease in arterial stiffness equivalent to a four-year reduction in their 'arterial age', and a drop in systolic (when heart muscles contract) and diastolic (when the muscles relax) blood pressure of 4 and 3mmHg respectively.

The findings show "it is possible to reverse the consequences of ageing on our blood vessels with real-world exercise in just six months", Manisty said.

"These were not people who were doing extreme levels of exercise or losing extreme amounts of weight. They were doing moderate training and reaching realistic running goals," she added in a telephone interview.

Metin Avkiran, a director at the British Heart Foundation charity which co-funded the research, said in a statement that the results showed the "undeniable" benefits of exercise.

"As the old mantra goes, if exercise were a pill it would be hailed as a wonder drug," he said.

(Reuters)

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less